Literature DB >> 33694267

The Independent Risk of Obesity and Diabetes and Their Interaction in COVID-19: A Retrospective Cohort Study.

Beverly G Tchang1, Gulce Askin2, Ageline Sahagun3, Jonathan Hwang3, Hao Huang3, Felicia A Mendelsohn Curanaj4, Jane J Seley4, Monika M Safford5, Laura C Alonso4, Louis J Aronne1, Alpana P Shukla1.   

Abstract

OBJECTIVE: This study aimed to assess whether diabetes mellitus (DM) or obesity is an independent risk factor for severe coronavirus disease 2019 (COVID-19) outcomes and to explore whether the risk conferred by one condition is modified by the other.
METHODS: This retrospective cohort study of inpatient adults with COVID-19 used multivariable Cox regression to determine the independent effects of DM and obesity on the composite outcome of intubation, intensive care unit admission, or in-hospital mortality. Effect modification between DM and obesity was assessed with a statistical interaction term and an exploration of stratum-specific effects.
RESULTS: Out of 3,533 patients, a total of 1,134 (32%) had DM, 1,256 (36%) had obesity, and 430 (12%) had both. DM and obesity were independently associated with the composite outcome (hazard ratio [HR] 1.14 [95% CI: 1.01-1.30] and HR 1.22 [95% CI: 1.05-1.43], respectively). A statistical trend for potential interaction between DM and obesity was observed (P = 0.20). Stratified analyses showed potential increased risk with obesity compared with normal weight among patients with DM (HR 1.34 [95% CI: 1.04-1.74]) and patients without DM (HR 1.18 [95% CI: 0.96-1.43]).
CONCLUSIONS: DM and obesity are independent risk factors associated with COVID-19 severity. Stratified analyses suggest that obesity may confer greater risk to patients with DM compared with patients without DM, and this relationship requires further exploration.
© 2021 The Obesity Society.

Entities:  

Mesh:

Year:  2021        PMID: 33694267     DOI: 10.1002/oby.23172

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  6 in total

1.  Association of Obesity With COVID-19 Severity and Mortality: An Updated Systemic Review, Meta-Analysis, and Meta-Regression.

Authors:  Romil Singh; Sawai Singh Rathore; Hira Khan; Smruti Karale; Yogesh Chawla; Kinza Iqbal; Abhishek Bhurwal; Aysun Tekin; Nirpeksh Jain; Ishita Mehra; Sohini Anand; Sanjana Reddy; Nikhil Sharma; Guneet Singh Sidhu; Anastasios Panagopoulos; Vishwanath Pattan; Rahul Kashyap; Vikas Bansal
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-03       Impact factor: 6.055

Review 2.  Diabetes and SARS-CoV-2-Is There a Mutual Connection?

Authors:  Anna P Jedrzejak; Edyta K Urbaniak; Jadwiga A Wasko; Natalia Ziojla; Malgorzata Borowiak
Journal:  Front Cell Dev Biol       Date:  2022-06-13

3.  Mortality and Clinical Outcomes among Patients with COVID-19 and Diabetes.

Authors:  Viny Kantroo; Manjit S Kanwar; Piyush Goyal; Deepak Rosha; Nikhil Modi; Avdhesh Bansal; Athar Parvez Ansari; Subhash Kumar Wangnoo; Sanjay Sobti; Sudha Kansal; Rajesh Chawla; Sanjiv Jasuja; Ishan Gupta
Journal:  Med Sci (Basel)       Date:  2021-10-26

4.  Duodenal Mucosal Expression of COVID-19-Related Genes in Health, Diabetic Gastroenteropathy, and Functional Dyspepsia.

Authors:  Brototo Deb; Daniel R O'Brien; Zainali S Chunawala; Adil E Bharucha
Journal:  J Clin Endocrinol Metab       Date:  2022-05-17       Impact factor: 6.134

5.  Newly diagnosed diabetes vs. pre-existing diabetes upon admission for COVID-19: Associated factors, short-term outcomes, and long-term glycemic phenotypes.

Authors:  Sara J Cromer; Caitlin Colling; Daria Schatoff; Michael Leary; Maria I Stamou; Daryl J Selen; Melissa S Putman; Deborah J Wexler
Journal:  J Diabetes Complications       Date:  2022-02-04       Impact factor: 2.852

6.  Comparing body mass index and obesity-related comorbidities as predictors in hospitalized COVID-19 patients.

Authors:  Michael W Tsoulis; Victor L Garcia; Wei Hou; Chrisa Arcan; Joshua D Miller
Journal:  Clin Obes       Date:  2022-02-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.